135 related articles for article (PubMed ID: 22143660)
41. Intralymphatic autochthonous tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A; McGrath D; Hutson C
J Biol Response Mod; 1986 Apr; 5(2):168-75. PubMed ID: 3734843
[TBL] [Abstract][Full Text] [Related]
42. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners.
Linek M; Favrot C
Vet Dermatol; 2010 Oct; 21(5):456-62. PubMed ID: 20492625
[TBL] [Abstract][Full Text] [Related]
43. Opinions of Finnish small animal owners about surgery and pain management in small animals.
Väisänen MA; Tuomikoski-Alin SK; Brodbelt DC; Vainio OM
J Small Anim Pract; 2008 Dec; 49(12):626-32. PubMed ID: 18793254
[TBL] [Abstract][Full Text] [Related]
44. Clinical outcomes of 30 cases (1997-2004) of canine gastrointestinal lymphoma.
Frank JD; Reimer SB; Kass PH; Kiupel M
J Am Anim Hosp Assoc; 2007; 43(6):313-21. PubMed ID: 17975213
[TBL] [Abstract][Full Text] [Related]
45. Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).
Chan CM; Frimberger AE; Moore AS
Vet Dermatol; 2018 Apr; 29(2):154-e59. PubMed ID: 28983988
[TBL] [Abstract][Full Text] [Related]
46. Owner satisfaction with partial mandibulectomy or maxillectomy for treatment of oral tumors in 27 dogs.
Fox LE; Geoghegan SL; Davis LH; Hartzel JS; Kubilis P; Gruber LA
J Am Anim Hosp Assoc; 1997; 33(1):25-31. PubMed ID: 8974022
[TBL] [Abstract][Full Text] [Related]
47. Owners 'perception of their cats' quality of life during COP chemotherapy for lymphoma.
Tzannes S; Hammond MF; Murphy S; Sparkes A; Blackwood L
J Feline Med Surg; 2008 Feb; 10(1):73-81. PubMed ID: 17827048
[TBL] [Abstract][Full Text] [Related]
48. Study of dog and cat owners' perceptions of medical treatment for cancer.
Brønden LB; Rutteman GR; Flagstad A; Teske E
Vet Rec; 2003 Jan; 152(3):77-80. PubMed ID: 12570310
[TBL] [Abstract][Full Text] [Related]
49. Actinomycin D for reinduction of remission in dogs with resistant lymphoma.
Moore AS; Ogilvie GK; Vail DM
J Vet Intern Med; 1994; 8(5):343-4. PubMed ID: 7837110
[TBL] [Abstract][Full Text] [Related]
50. Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma.
Ruslander D; Moore AS; Gliatto JM; L'Heureux D; Cotter SM
J Vet Intern Med; 1994; 8(4):299-301. PubMed ID: 7983628
[TBL] [Abstract][Full Text] [Related]
51. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
Alexandrakis I; Tuli R; Ractliffe SC; Tappin SW; Foale RD; Roos A; Slater KJ
Vet Comp Oncol; 2017 Mar; 15(1):6-17. PubMed ID: 25319380
[TBL] [Abstract][Full Text] [Related]
52. Owner assessment of the outcome of total hip arthroplasty in dogs.
Skurla CT; Egger EL; Schwarz PD; James SP
J Am Vet Med Assoc; 2000 Oct; 217(7):1010-2. PubMed ID: 11019706
[TBL] [Abstract][Full Text] [Related]
53. Serial haemostatic monitoring of dogs with multicentric lymphoma.
Kol A; Marks SL; Skorupski KA; Kass PH; Guerrero T; Gosselin RC; Borjesson DL
Vet Comp Oncol; 2015 Sep; 13(3):255-66. PubMed ID: 23710569
[TBL] [Abstract][Full Text] [Related]
54. Owners' perception of their dogs' quality of life during and after radiotherapy for cancer.
Serras AR; Berlato D; Murphy S
J Small Anim Pract; 2019 May; 60(5):268-273. PubMed ID: 30618206
[TBL] [Abstract][Full Text] [Related]
55. Prognostic role of clinical presentation, cytological picture and response to treatment in canine centroblastic lymphoma.
Kliczkowska-Klarowicz K; Jagielski D; Czopowicz M; Sapierzyński R
Pol J Vet Sci; 2021 Mar; 24(1):101-107. PubMed ID: 33847104
[TBL] [Abstract][Full Text] [Related]
56. Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma.
Gramer I; Kessler M; Geyer J
Vet Comp Oncol; 2015 Dec; 13(4):363-72. PubMed ID: 23834200
[TBL] [Abstract][Full Text] [Related]
57. Survival time, lifespan, and quality of life in dogs with idiopathic Fanconi syndrome.
Yearley JH; Hancock DD; Mealey KL
J Am Vet Med Assoc; 2004 Aug; 225(3):377-83. PubMed ID: 15328712
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapy and remission status do not alter pre-existing innate immune dysfunction in dogs with lymphoma.
Axiak-Bechtel S; Fowler B; Yu DH; Amorim J; Tsuruta K; DeClue A
Res Vet Sci; 2014 Oct; 97(2):230-7. PubMed ID: 25108839
[TBL] [Abstract][Full Text] [Related]
59. Assessing major influences on decision-making and outcome for dogs presenting emergently with nontraumatic hemoabdomen.
Menard JV; Sylvester SR; Lopez DJ
J Am Vet Med Assoc; 2023 Jul; 261(7):980-988. PubMed ID: 37116877
[TBL] [Abstract][Full Text] [Related]
60. Validation and preliminary data from a health-related quality of life questionnaire for owners of dogs with cardiac disease.
Freeman LM; Rush JE; Clark MA; Bulmer BJ
J Vet Intern Med; 2020 May; 34(3):1119-1126. PubMed ID: 32396234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
